1. Home
  2. MCHX vs TLSA Comparison

MCHX vs TLSA Comparison

Compare MCHX & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • TLSA
  • Stock Information
  • Founded
  • MCHX 2003
  • TLSA 2013
  • Country
  • MCHX United States
  • TLSA United Kingdom
  • Employees
  • MCHX N/A
  • TLSA N/A
  • Industry
  • MCHX Business Services
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • TLSA Health Care
  • Exchange
  • MCHX Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • MCHX 84.3M
  • TLSA 87.8M
  • IPO Year
  • MCHX 2004
  • TLSA 2000
  • Fundamental
  • Price
  • MCHX $2.07
  • TLSA $0.79
  • Analyst Decision
  • MCHX
  • TLSA
  • Analyst Count
  • MCHX 0
  • TLSA 0
  • Target Price
  • MCHX N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • MCHX 33.9K
  • TLSA 1.1M
  • Earning Date
  • MCHX 03-13-2025
  • TLSA 02-25-2025
  • Dividend Yield
  • MCHX N/A
  • TLSA N/A
  • EPS Growth
  • MCHX N/A
  • TLSA N/A
  • EPS
  • MCHX N/A
  • TLSA N/A
  • Revenue
  • MCHX $48,594,000.00
  • TLSA N/A
  • Revenue This Year
  • MCHX N/A
  • TLSA N/A
  • Revenue Next Year
  • MCHX $4.63
  • TLSA N/A
  • P/E Ratio
  • MCHX N/A
  • TLSA N/A
  • Revenue Growth
  • MCHX N/A
  • TLSA N/A
  • 52 Week Low
  • MCHX $1.11
  • TLSA $0.41
  • 52 Week High
  • MCHX $2.40
  • TLSA $1.74
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 60.01
  • TLSA 56.56
  • Support Level
  • MCHX $1.88
  • TLSA $0.65
  • Resistance Level
  • MCHX $2.04
  • TLSA $0.70
  • Average True Range (ATR)
  • MCHX 0.09
  • TLSA 0.05
  • MACD
  • MCHX 0.01
  • TLSA 0.01
  • Stochastic Oscillator
  • MCHX 90.48
  • TLSA 100.00

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: